Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

ClinicalTrials.gov ID: NCT03887520

Public ClinicalTrials.gov record NCT03887520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center Cross-sectional Epidemiological Study to Characterize the Prevalence and Distribution of Lipoprotein(a) Levels Among Patients With Established Cardiovascular Disease

Study identification

NCT ID
NCT03887520
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
49,001 participants

Conditions and interventions

Interventions

  • Blood draw for Lp(a) Diagnostic Test

Diagnostic Test

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 26, 2018
Primary completion
Jul 29, 2021
Completion
Jul 29, 2021
Last update posted
Jan 27, 2022

2018 – 2021

United States locations

U.S. sites
180
U.S. states
38
U.S. cities
153
Facility City State ZIP Site status
Novartis Investigative Site Andalusia Alabama 36420
Novartis Investigative Site Birmingham Alabama 35243
Novartis Investigative Site Huntsville Alabama 35801
Novartis Investigative Site Mobile Alabama 36608
Novartis Investigative Site Cottonwood Arizona 86326
Novartis Investigative Site Mesa Arizona 85206
Novartis Investigative Site Surprise Arizona 85374
Novartis Investigative Site Tucson Arizona 85745
Novartis Investigative Site Little Rock Arkansas 72204
Novartis Investigative Site Beverly Hills California 90211
Novartis Investigative Site Concord California 94520
Novartis Investigative Site Covina California 91723
Novartis Investigative Site Fresno California 93720
Novartis Investigative Site Huntington Beach California 92648
Novartis Investigative Site Long Beach California 90806
Novartis Investigative Site Los Angeles California 90033
Novartis Investigative Site Los Angeles California 90073
Novartis Investigative Site Northridge California 91325
Novartis Investigative Site Orange California 92868
Novartis Investigative Site Orangevale California 95662
Novartis Investigative Site San Diego California 92103
Novartis Investigative Site San Francisco California 94143
Novartis Investigative Site Santa Ana California 92704
Novartis Investigative Site Stanford California 94305
Novartis Investigative Site Stockton California 95204
Novartis Investigative Site Torrance California 90502
Novartis Investigative Site West Hills California 91307
Novartis Investigative Site Aurora Colorado 80045
Novartis Investigative Site Bridgeport Connecticut 06610
Novartis Investigative Site Hartford Connecticut 06102-5037
Novartis Investigative Site Waterbury Connecticut 06708
Novartis Investigative Site Boca Raton Florida 33434
Novartis Investigative Site Bradenton Florida 34209
Novartis Investigative Site Brandon Florida 33511
Novartis Investigative Site Hollywood Florida 33312
Novartis Investigative Site Jacksonville Florida 32205
Novartis Investigative Site Jacksonville Florida 32216
Novartis Investigative Site Jacksonville Florida 32223
Novartis Investigative Site Miami Florida 33133
Novartis Investigative Site Miami Florida 33176
Novartis Investigative Site Naples Florida 34102
Novartis Investigative Site Port Charlotte Florida 33952
Novartis Investigative Site Port Orange Florida 32127
Novartis Investigative Site Saint Augustine Florida 32086
Novartis Investigative Site Tampa Florida 33612
Novartis Investigative Site Wellington Florida 33449
Novartis Investigative Site Atlanta Georgia 30084
Novartis Investigative Site Atlanta Georgia 30309
Novartis Investigative Site Atlanta Georgia 30322
Novartis Investigative Site Dunwoody Georgia 30338
Novartis Investigative Site Thomasville Georgia 31792
Novartis Investigative Site Chicago Illinois 60612
Novartis Investigative Site Lombard Illinois 60148
Novartis Investigative Site Park Ridge Illinois 60068
Novartis Investigative Site Skokie Illinois 60077
Novartis Investigative Site Indianapolis Indiana 46202 4800
Novartis Investigative Site Indianapolis Indiana 46260
Novartis Investigative Site Iowa City Iowa 52242
Novartis Investigative Site Kansas City Kansas 66160
Novartis Investigative Site Topeka Kansas 66606
Novartis Investigative Site Louisville Kentucky 40213
Novartis Investigative Site Alexandria Louisiana 71301
Novartis Investigative Site Baton Rouge Louisiana 70808
Novartis Investigative Site Covington Louisiana 70433
Novartis Investigative Site Hammond Louisiana 70403
Novartis Investigative Site Houma Louisiana 70360
Novartis Investigative Site Lafayette Louisiana 70501
Novartis Investigative Site Metairie Louisiana 70006
Novartis Investigative Site New Orleans Louisiana 70112
Novartis Investigative Site New Orleans Louisiana 70115
Novartis Investigative Site Opelousas Louisiana 70570
Novartis Investigative Site Shreveport Louisiana 71101
Novartis Investigative Site Slidell Louisiana 70458
Novartis Investigative Site Zachary Louisiana 70791
Novartis Investigative Site Scarborough Maine 04074
Novartis Investigative Site Baltimore Maryland 21201
Novartis Investigative Site Baltimore Maryland 21209
Novartis Investigative Site Baltimore Maryland 21287
Novartis Investigative Site Columbia Maryland 21044
Novartis Investigative Site Ft. Washington Maryland 20744
Novartis Investigative Site Rockville Maryland 20850
Novartis Investigative Site Boston Massachusetts 02114-2696
Novartis Investigative Site Boston Massachusetts 02115
Novartis Investigative Site Bingham Farms Michigan 48025
Novartis Investigative Site Detroit Michigan 48201
Novartis Investigative Site Detroit Michigan 48202
Novartis Investigative Site Flint Michigan 48504
Novartis Investigative Site Grand Blanc Michigan 48439
Novartis Investigative Site Kalamazoo Michigan 49008
Novartis Investigative Site Midland Michigan 48640
Novartis Investigative Site Petoskey Michigan 49770
Novartis Investigative Site Saginaw Michigan 48601
Novartis Investigative Site Wyoming Michigan 49519
Novartis Investigative Site Minneapolis Minnesota 55407
Novartis Investigative Site Minneapolis Minnesota 55455
Novartis Investigative Site Saint Paul Minnesota 55102
Novartis Investigative Site Belzoni Mississippi 39038
Novartis Investigative Site Jackson Mississippi 39209
Novartis Investigative Site Southaven Mississippi 38671
Novartis Investigative Site Yazoo City Mississippi 39194
Novartis Investigative Site City of Saint Peters Missouri 63303
Novartis Investigative Site St Louis Missouri 63110
Novartis Investigative Site St Louis Missouri 63128
Novartis Investigative Site St Louis Missouri 63141
Novartis Investigative Site Lincoln Nebraska 68526
Novartis Investigative Site Omaha Nebraska 68114
Novartis Investigative Site Omaha Nebraska 68134
Novartis Investigative Site Lebanon New Hampshire 03756
Novartis Investigative Site Nashua New Hampshire 03060
Novartis Investigative Site Ridgewood New Jersey 07450
Novartis Investigative Site Summit New Jersey 07901
Novartis Investigative Site Albany New York 12206
Novartis Investigative Site Binghamton New York 13901
Novartis Investigative Site Endwell New York 13760
Novartis Investigative Site Manhasset New York 11030
Novartis Investigative Site New York New York 10016
Novartis Investigative Site New York New York 10021
Novartis Investigative Site New York New York 10029
Novartis Investigative Site New York New York 43210
Novartis Investigative Site North Massapequa New York 11758
Novartis Investigative Site Riverhead New York 11901
Novartis Investigative Site Rochester New York 14642
Novartis Investigative Site The Bronx New York 10467 2490
Novartis Investigative Site Charlotte North Carolina 28204
Novartis Investigative Site Greensboro North Carolina 27408
Novartis Investigative Site Morehead City North Carolina 28557
Novartis Investigative Site Raleigh North Carolina 27609
Novartis Investigative Site Sanford North Carolina 27330
Novartis Investigative Site Shelby North Carolina 28150
Novartis Investigative Site Winston-Salem North Carolina 27157
Novartis Investigative Site Akron Ohio 44309
Novartis Investigative Site Canton Ohio 44710
Novartis Investigative Site Cincinnati Ohio 45219
Novartis Investigative Site Cincinnati Ohio 45246
Novartis Investigative Site Cincinnati Ohio 45267
Novartis Investigative Site Cleveland Ohio 44195
Novartis Investigative Site Marion Ohio 43302
Novartis Investigative Site Portland Oregon 97239
Novartis Investigative Site Lancaster Pennsylvania 17603
Novartis Investigative Site Lansdale Pennsylvania 19446
Novartis Investigative Site Philadelphia Pennsylvania 19104
Novartis Investigative Site Pittsburgh Pennsylvania 15212
Novartis Investigative Site Yardley Pennsylvania 19067
Novartis Investigative Site Providence Rhode Island 02906
Novartis Investigative Site Fort Mill South Carolina 29707
Novartis Investigative Site Summerville South Carolina 29485
Novartis Investigative Site Rapid City South Dakota 57701
Novartis Investigative Site Germantown Tennessee 38138
Novartis Investigative Site Jackson Tennessee 38301
Novartis Investigative Site Knoxville Tennessee 37917
Novartis Investigative Site Nashville Tennessee 37203
Novartis Investigative Site Nashville Tennessee 37232
Novartis Investigative Site Beaumont Texas 77702
Novartis Investigative Site Dallas Texas 75226
Novartis Investigative Site Dallas Texas 75231
Novartis Investigative Site Dallas Texas 75235
Novartis Investigative Site Dallas Texas 75390
Novartis Investigative Site Houston Texas 77030
Novartis Investigative Site Livingston Texas 77351
Novartis Investigative Site Lufkin Texas 75904
Novartis Investigative Site Marshall Texas 75670
Novartis Investigative Site Plano Texas 75093
Novartis Investigative Site Sugar Land Texas 77479
Novartis Investigative Site Temple Texas 76508
Novartis Investigative Site Tomball Texas 77375
Novartis Investigative Site Bountiful Utah 84010
Novartis Investigative Site Layton Utah 84041
Novartis Investigative Site Murray Utah 84107
Novartis Investigative Site Salt Lake City Utah 84132
Novartis Investigative Site Danville Virginia 24541
Novartis Investigative Site Falls Church Virginia 22042
Novartis Investigative Site Manassas Virginia 20109
Novartis Investigative Site Norfolk Virginia 23510
Novartis Investigative Site Richmond Virginia 23219
Novartis Investigative Site Seattle Washington 98104
Novartis Investigative Site Seattle Washington 98122
Novartis Investigative Site Seattle Washington 98195
Novartis Investigative Site Tacoma Washington 98405
Novartis Investigative Site Madison Wisconsin 53705
Novartis Investigative Site Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 720 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03887520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03887520 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →